Who is clarity pharmaceutical?

We are a clinical stage radiopharmaceutical company developing next-generation products to address the growing need for the use of radiopharmaceuticals in oncology. At Clarity, our mission is to develop next-generation radiopharmaceutical products that improve treatment outcomes for children and adults with cancer.

Is clarity a radiopharmaceutical company?

Clarity’s Executive Chairperson, Dr Alan Taylor, commented: “Clarity is very well positioned for what is quickly becoming a radiopharmaceuticals revolution. We are very proud of our achievements to date, and of being the only true Australian radiopharmaceutical company that has developed our products at the benchtop of Australian science.

Which Clarity products are in clinical development?

Clarity’s lead product SARTATE™, an oncology theranostic (diagnostic and therapy), is in clinical trials for neuroblastoma and neuroendocrine tumours. Clarity’s next product, SAR-bisPSMA for the treatment of prostate cancer, is in clinical development as a stand alone diagnostic as well as a theranostic product.